Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30


The Black Book of Psychotropic Dosing and Monitoring.

Schatzberg AF, Charles D.

Psychopharmacol Bull. 2018 Jan 15;48(1):64-153. No abstract available.


Non-24-Hour Sleep-Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management.

Quera Salva MA, Hartley S, Léger D, Dauvilliers YA.

Front Neurol. 2017 Dec 18;8:686. doi: 10.3389/fneur.2017.00686. eCollection 2017. Review.


Medications for Sleep Schedule Adjustments in Athletes.

Baird MB, Asif IM.

Sports Health. 2018 Jan/Feb;10(1):35-39. doi: 10.1177/1941738117743205. Epub 2017 Nov 21. Review.


Clock-Enhancing Small Molecules and Potential Applications in Chronic Diseases and Aging.

Gloston GF, Yoo SH, Chen ZJ.

Front Neurol. 2017 Mar 15;8:100. doi: 10.3389/fneur.2017.00100. eCollection 2017. Review.


Systems Chronotherapeutics.

Ballesta A, Innominato PF, Dallmann R, Rand DA, Lévi FA.

Pharmacol Rev. 2017 Apr;69(2):161-199. doi: 10.1124/pr.116.013441. Review.


Administration of Melatonin and Metformin Prevents Deleterious Effects of Circadian Disruption and Obesity in Male Rats.

Thomas AP, Hoang J, Vongbunyong K, Nguyen A, Rakshit K, Matveyenko AV.

Endocrinology. 2016 Dec;157(12):4720-4731. Epub 2016 Sep 21.


Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.

Williams WP 3rd, McLin DE 3rd, Dressman MA, Neubauer DN.

Pharmacotherapy. 2016 Sep;36(9):1028-41. doi: 10.1002/phar.1822. Epub 2016 Sep 1. Review.


Update on melatonin receptors: IUPHAR Review 20.

Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, Cecon E, Zlotos DP.

Br J Pharmacol. 2016 Sep;173(18):2702-25. doi: 10.1111/bph.13536. Epub 2016 Aug 8. Review.


Melatonin Therapy in Patients with Alzheimer's Disease.

Cardinali DP, Vigo DE, Olivar N, Vidal MF, Brusco LI.

Antioxidants (Basel). 2014 Apr 10;3(2):245-77. doi: 10.3390/antiox3020245. Review.


Effect of Light and Melatonin and Other Melatonin Receptor Agonists on Human Circadian Physiology.

Emens JS, Burgess HJ.

Sleep Med Clin. 2015 Dec;10(4):435-53. doi: 10.1016/j.jsmc.2015.08.001. Epub 2015 Sep 7. Review.


MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.

Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML.

Annu Rev Pharmacol Toxicol. 2016;56:361-83. doi: 10.1146/annurev-pharmtox-010814-124742. Epub 2015 Oct 23. Review.


Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily.

Roth BL, Kroeze WK.

J Biol Chem. 2015 Aug 7;290(32):19471-7. doi: 10.1074/jbc.R115.654764. Epub 2015 Jun 22. Review.


Synthetic melatoninergic ligands: achievements and prospects.

Kostiuk NV, Belyakova MB, Leshchenko DV, Zhigulina VV, Miniaev MV.

ISRN Biochem. 2014 Feb 23;2014:843478. doi: 10.1155/2014/843478. eCollection 2014. Review.


Melatonergic drugs in development.

Carocci A, Catalano A, Sinicropi MS.

Clin Pharmacol. 2014 Sep 18;6:127-37. doi: 10.2147/CPAA.S36600. eCollection 2014. Review.


Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.

Laudon M, Frydman-Marom A.

Int J Mol Sci. 2014 Sep 9;15(9):15924-50. doi: 10.3390/ijms150915924. Review.


Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression.

Hickie IB, Naismith SL, Robillard R, Scott EM, Hermens DF.

BMC Med. 2013 Mar 22;11:79. doi: 10.1186/1741-7015-11-79.


Therapeutic application of melatonin in mild cognitive impairment.

Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI.

Am J Neurodegener Dis. 2012;1(3):280-91. Epub 2012 Nov 18.


Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival.

Oprea-Ilies G, Haus E, Sackett-Lundeen L, Liu Y, McLendon L, Busch R, Adams A, Cohen C.

Breast Cancer Res Treat. 2013 Feb;137(3):677-87. doi: 10.1007/s10549-012-2371-3. Epub 2012 Dec 19.


Sleep physiology, abnormal States, and therapeutic interventions.

Wickboldt AT, Bowen AF, Kaye AJ, Kaye AM, Rivera Bueno F, Kaye AD.

Ochsner J. 2012 Summer;12(2):122-34.

Supplemental Content

Support Center